JamesM.SchmitzMD

PubMed

• 167 citations
  Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology.
  E K van den Berg, James M Schmitz, C R Benedict, Craig R. Malloy, James T. Willerson
  Circulation. 1989-01-01
• 32 citations
  Orally Active Epoxyeicosatrienoic Acid Analogs.
  William B. Campbell, John D. Imig, James M. Schmitz, John R. Falck
  Journal of Cardiovascular Pharmacology. 2017-10-01
• 78 citations
  The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.
  L R Bush, William B. Campbell, K Kern, G D Tilton, P Apprill
  Circulation Research. 1984-11-01

Journal Articles

• Omega -3 fatty acids for reducing recurrence of stenosis after coronary angioplasty.  
  Dehmer GJ, Popma JJ, van den Berg EK, Eichhorn EJ, Willerson JT, Schmitz JM, Cardiol Board Rev, 1/1/1990
• Effect of dietary Omega-3 fatty acid supplementation on serum lipids, platelet fatty acids and function and atherosclerosis in the Watanabe Heritable Hyperlipidemic ra...  
  Clubb FJ, Schmitz JM, Butler MM, Buja LM, Willerson JT and Campbell WB, Arteriosclerosis, 1/1/1989
• Eicosapentaenoic acid alters vascular reactivity and platelet adhesion in Watanabe Heritable Hyperlipidemic rabbits.  
  Pfister SL, Rosolowsky M, Schmitz JM, Clubb FJ, Jr. and Campbell WB, Eur J Pharmacol, 1/1/1989
• Reduction in Coronary Restenosis with N-3 Fatty Acids(Correspondence)  
  Dehmer GJ, Schmitz JM, Willerson JT, N Engl J Med, 1/1/1989
• Transcardiac serotonin concentration is increased in selected patients with limiting angina and complex coronary lesion morphology.  
  Van den Berg EK, Schmitz JM, Benedict CR, Malloy CR, Willerson ST, Dehmer GJ, Circ, 1/1/1989
• Augmented vasoconstrictor response to serotonin precede the development of atherosclerosis in the aorta of the WHHL rabbits.  
  Wines PA, Schmitz JM, Pfister SL, Clubb FJ, Buja LM, Willerson JT, Campbell WB, Arteriosclerosis, 1/1/1989
• Clinical and hemodynamic characteristics of patients with inducible pulsus alternans.  
  Schaefer S, Malloy CR, Schmitz JM, Dehmer GJ, Am Heart J, 1/1/1988
• Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with omega-3 fatty acids.  
  Dehmer GJ, Popma JJ, Van den Berg EK, Eichhorn EJ, Prewitt JB, Campbell WB, Jennings L, Willerson JT, Schmitz JM, N Engl J Med, 1/1/1988
• Characterization of arachidonic acid metabolism in Watanabe Heritable hyperlipidemic and New Zealand white rabbit aortae.  
  Pfister SL, Schmitz JM, Willerson JT, Campbell WB, Prostaglandins, 1/1/1988
• Cooperative mediation by serotonin and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenosis.  
  Ashton JH, Ogeltree ML, Michel IN, Taylor AL, Raheja S, Schmitz JM, Buja LM, Campbell WB, Willerson JT, Circ, 1/1/1987
• Plasma serotonin concentrations: Validation of a sampling technique using long catheters.  
  Van den Berg EK, Schmitz JM, Benedict CR, Prewitt JB, Malloy CR, Willerson JT, Dehmer GJ, AM J Med Sci, 1/1/1987
• Anticoagulation with heparin during cardiac catheterization and its reversal by protamine.  
  Dehmer GJ, Haagen D, Malloy CR, Schmitz JM, Cathet Cardiovasc Diagn, 1/1/1987
• A new technique for cannulation of the coronary sinus from the femoral vein.  
  Dehmer GJ, Schmitz JM, Malloy CR, Cathet. Cardiovasc Diagn, 1/1/1986
• Inhibition of cyclic flow variations in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists.  
  Ashton JH, Schmitz JM, Campbell WB, Ogeltree ML, Raheja S, Taylor AL, Fitzgerald C, Buja LM, Willerson JT, Circ Res, 1/1/1986
• Platelet activating factor acts independent of thromboxane or serotonin in modulating acute coronary ischemia in the dog.  
  Apprill P, Schmitz JM, Ashton J, Campbell WB, Willerson J, Circ, 1/1/1985
• Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia.  
  Schmitz JM, Campbell WB, Apprill P, Willerson J, Circ Res, 1/1/1985
• Conversion from chronic to acute ischemic heart disease: speculation regarding mechanisms.  
  Willerson JR, Campbell WB, Winniford MD, Schmitz JM, Apprill P, Firth N, Aston J, Smitherman R, Bush L, Buja LM, Am J Cardio, 1/1/1984
• The effects of alpha adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries.  
  Bush LR, Campbell WB, Kern K, Tilton G, Apprill P, Schmitz JM, Buja L, Willerson JT, Circ Res, 1/1/1984
• Renal alpha-1 and alpha-2 adrenergic receptors: Biochemical and pharmacological correlations.  
  Schmitz JM, Graham RM, Sagalowski A, and Pettinger WA, J Pharmocol Exp Ther, 1/1/1981
• Alterations of angiotensin-induced aldosterone release by inhibitors of prostaglandin synthesis.  
  Campbell WB, Gomez-Sanchez CE, Adams B, Schmitz JM and Itskovitz HD, J Clin Invest, 1/1/1979
• Effect of sodium depletion on the steroidogenic and pressor activities of angiotensin.  
  Campbell WB, Schmitz JM and Itskovitz HD, Clin Sci, 1/1/1979
• Angiotensin III: A relatively selective adrenal agonist of the renin-angiotensin system.  
  Campbell WB, Schmitz JM, Eur J Pharmocol, 1/1/1979
• Effects of alterations in dietary potassium on the pressor and steroidogenic effects of angiotensin II and III.  
  Campbell WB, Schmitz JM, Endocrinology, 1/1/1978
• Adrenal and vascular effects of angiotensin II and III in sodium depleted rats  
  Campbell WB, Schmitz JM, and Itskovitz HD, Life Sci, 1/1/1977
• (Des1 - Asp) angiotensin I: A Study of its pressor and steroidogenic activities in conscious rats.  
  Campbell WB, Schmitz, JM, Itskovitz HD, Endocrinology, 1/1/1976
• Join now to see all